[ad_1]
The bed manufacturer's business figure was lower than what experts had anticipated. According to experts, the fact that the company recorded a gross loss in the books was also a surprise. Especially in Germany, Beter Bed's biggest market, it went bad as a result of a toxic scandal with foam mattresses.
,, The results are a real shock given the magnitude of gross loss and cost uncertainty. "We have to reverse the trend in Germany," writes the NIBC
. Careful
In KBC also, they point out the poor performance in Germany, but the experts have already taken into account the lower results. The problems on Beter Bed 's largest market still weigh in the results, which is what is expected.
According to ING, the company still has no long term prospects and the company promises a strategic update in the last quarter of the year. KBC stresses that investors will be cautious until the moment when there will be more clarity as to the strategy to follow
Hold
ING maintains its consulting position with a price target n 13 euros. NIBC uses buying tips with a price target of 13.50 euros. KBC has lowered its price target to EUR 7 and is using investment advice on Beter Bed.
Beter Bed's share was almost 7.1% lower at 6.26 euros on Friday at 10:20
Source link